BDX Chart

1 Month

	Date	Diff
	2025-05-05	-1.05 %
Becton, Dickinson and Company (BDX) stock declined by -1.05% after Stifel Nicolaus lowered its price target significantly from $280 to $224 and following multiple downgrades from other analysts, impacting investor sentiment. Becton Dickinson (BDX) stock declined by 1.05% to $168.61 amid a higher trading volume than average, potentially influenced by market fluctuations affecting pharmaceutical stocks as well as factors such as clinical trial results, regulatory decisions, and economic conditions impacting the healthcare sector. Becton, Dickinson and Company's (BDX) stock declined by -1.05% following a series of downgrades from multiple brokerages, including Piper Sandler, which reduced its rating from overweight to neutral and lowered its price target significantly, indicating a cautious outlook on the stock.
	2025-05-02	-0.45 %
Becton Dickinson (BDX) stock fell by 0.45% after the company lowered its fiscal year 2025 guidance and highlighted the impact of tariffs, despite reporting higher adjusted earnings per share that exceeded analysts' expectations.
	2025-05-01	-18.13 %
Becton Dickinson (BDX) stock dropped by 18.13% due to disappointing earnings reports and guidance, contributing to a significant decline in investor confidence amidst a generally positive market for tech stocks.
	2025-04-30	+0.31 %
Becton, Dickinson and Company (BDX) stock rose by 0.31% due to strong earnings performance that exceeded analysts' expectations, as well as the announcement of a stock repurchase plan indicating the board's belief that the stock is undervalued. Becton, Dickinson and Company (BDX) stock rose by 0.31% ahead of its anticipated Q2 2025 earnings release, where analysts expect positive results, including earnings of $3.28 per share and revenue of $5.35 billion, alongside recent actions like a stock buyback plan indicating confidence in the stock’s value.
	2025-04-25	+0.31 %
The article discusses how T. Rowe Price is experiencing significant growth in actively managed exchange-traded funds (ETFs), with a specific mention of the T. Rowe Price Capital Appreciation Equity ETF and its holdings, including Becton Dickinson (BDX), which is up by 0.31% due to the attractiveness of professional management in volatile market conditions. Becton Dickinson (BDX) stock likely went up as part of a broader trend of investment in actively managed funds, which are perceived to perform better in uncertain market environments.
	2025-04-15	-1.78 %
Becton, Dickinson and Company (BDX) stock declined by 1.78% following a revision by Zacks Research, which lowered its FY2025 earnings per share estimate from $14.43 to $14.40, signaling concerns over future profitability.
	2025-04-10	-4.89 %
Becton Dickinson (BDX) stock fell by 4.89% amidst unusual options trading activity and recent insider sales, which may have raised concerns among investors despite the company reporting strong earnings and announcing a share repurchase plan.
	2025-04-09	+4.24 %
Becton, Dickinson and Company (BDX) shares rose by 4.24% likely due to a combination of strong earnings performance, an upgraded "buy" rating from StockNews.com, and ongoing investor interest despite a lowered price target from Barclays.
	2025-04-04	-6.43 %
Becton, Dickinson and Company (BDX) stock fell by 6.43% due to concerns over its long-term growth potential compared to other investment opportunities, particularly in AI stocks, as highlighted by Generation Investment Management's recent investor letter.
	2025-04-02	+0.17 %
Becton, Dickinson and Company (BDX) stock rose by 0.17% following an upgrade from a "hold" to a "buy" rating by StockNews.com, amid positive sentiments from other analysts who also raised price targets for the stock.
	2025-03-27	+0.31 %
Becton, Dickinson and Company (BDX) stock rose 0.31% despite being downgraded to a "hold" rating, primarily due to positive earnings results exceeding analyst expectations and bullish price target increases from several analysts indicating strong market confidence.
	2025-03-24	-0.45 %
Becton, Dickinson and Company (BDX) stock decreased by 0.45% despite receiving positive recommendations from analysts, likely due to insider selling and market movements despite a generally favorable outlook.
	2025-03-14	+1.43 %
Becton, Dickinson and Company (BDX) stock rose by 1.43% despite a recent decline due to insider selling, as analysts upgraded their ratings and target prices, indicating confidence in the company's financial performance and future prospects.
	2025-03-11	-1.11 %
Becton, Dickinson and Company (BDX) stock declined by 1.11% primarily due to the reduction of holdings by institutional investors, including a notable 3.8% cut by Victory Capital Management, alongside ongoing stock trading activities and market fluctuations.
	2025-03-07	+1.86 %
Becton, Dickinson and Company (BDX) stock rose 1.86% following an upgrade from a "hold" to a "buy" rating by StockNews.com and positive price target adjustments from analysts, signaling improved investor confidence.
	2025-03-06	+0.54 %
Becton Dickinson (BDX) stock rose by 0.54% due to findings from a significant study highlighting the critical role of Musashi-2 (Msi2) in lung adenocarcinoma, which suggests potential new therapeutic targets and advancements in understanding cancer biology that may positively influence investor sentiment.
	2025-03-05	-0.07 %
Becton Dickinson (BDX) stock fell by 0.07% due to general market trends and possibly investor reactions to current geopolitical uncertainties affecting the healthcare industry. The article does not directly address Becton Dickinson (BDX) stock's decline of -0.07%, but it provides a detailed notice about Suominen Corporation’s upcoming Annual General Meeting, discussing various agenda items including the election of board members and financial statements. The decline in BDX stock could be attributed to market fluctuations, investor sentiments, or company-specific news, but such details are not covered in this article.
	2025-02-27	-1.51 %
Becton, Dickinson and Company (BDX) stock declined by 1.51% following a downgrade from a "buy" rating to a "hold" rating by StockNews.com, despite other analysts maintaining positive outlooks on the stock.
	2025-02-19	+1.08 %
Becton, Dickinson and Company (BDX) stock rose by 1.08% due to increased institutional investor interest, including a significant 56.5% stake increase by Allspring Global Investments, positive analyst ratings, an earnings beat in their last quarterly report, and the announcement of a share repurchase program indicating management's confidence in the stock's value. Becton, Dickinson and Company (NYSE: BDX) stock rose by 1.08% following positive quarterly earnings results that exceeded analysts' expectations, a new stock buyback program indicating potential undervaluation, and a general bullish sentiment reflected in upgrades and positive ratings from analysts.
	2025-02-07	+1.16 %
Becton, Dickinson and Company (BDX) saw its stock rise by 1.16% due to increased institutional investments, positive quarterly earnings that exceeded expectations, a stock buyback program indicating management's belief in the stock's undervaluation, and favorable research analyst ratings.
	2025-02-05	+1.09 %
Becton, Dickinson and Company (BDX) stock rose 1.09% ahead of its quarterly earnings announcement, driven by strong previous performance that exceeded analysts' expectations, a newly authorized stock repurchase plan indicating board confidence in the stock's value, and a favorable earnings outlook for the fiscal year.
	2025-02-04	-2.1 %
Becton, Dickinson and Company (BDX) stock fell by 2.1% amid mixed institutional investments and recent insider selling activity, despite positive earnings reports and an increase in analyst price targets.
	2025-01-30	+0.64 %
Becton, Dickinson and Company (BDX) stock rose by 0.64% following an upgrade and increased target price from analysts at Piper Sandler, indicating a positive outlook and potential upside for the stock.
	2025-01-27	+2.16 %
Becton, Dickinson and Company (BDX) stock rose by 2.16% due in part to significant increases in holdings by institutional investors, positive quarterly earnings that exceeded expectations, and favorable analyst ratings that suggest a potential for future growth. Becton, Dickinson and Company (BDX) stock rose by 2.16% due to increased investments from major institutional investors, strong quarterly earnings that exceeded expectations, and an upward revision of its dividend.
	2025-01-24	+1.24 %
Becton, Dickinson and Company (BDX) stock rose 1.24% following an upgrade by Citigroup from a "neutral" to a "buy" rating and an increase in their price objective for the stock, despite a slight reduction in FY2025 earnings estimates by Zacks Research.
	2025-01-22	-1.02 %
Becton Dickinson (BDX) stock fell by 1.02% as analysts favor Daxor (DXR) due to its higher potential upside, despite BDX outperforming in revenue and earnings compared to DXR. Becton, Dickinson and Company (NYSE: BDX) stock experienced a decline of -1.02% following recent insider selling activities by executive vice presidents and mixed ratings from analysts, despite an increase in institutional holdings and positive financial performance in previous quarters.
	2025-01-17	+0.46 %
Becton, Dickinson and Company (BDX) stock rose by 0.46% due to increasing interest and investment from institutional investors, including a notable purchase from Wedmont Private Capital, along with positive analyst upgrades and strong quarterly earnings that surpassed expectations.
	2025-01-16	+1.6 %
Becton Dickinson (BDX) stock rose by 1.6% following increased institutional investment and favorable quarterly earnings results that surpassed analysts' expectations, alongside a boosted dividend payout.
	2025-01-15	-1.36 %
Becton, Dickinson and Company (BDX) stock fell by 1.36% following a modest trimming of shares by Moody National Bank Trust Division and insider selling, alongside mixed ratings from research firms. Becton, Dickinson and Company (NYSE: BDX) experienced a 1.36% decline in its stock, which may be attributed to recent insider selling and fluctuating institutional investor positions, alongside market reactions to its dividend announcement and overall economic conditions.
	2025-01-14	-0.17 %
Becton Dickinson (BDX) stock recently fell by 0.17%, influenced by insider selling, mixed analyst ratings, and changes in hedge fund positions, despite the company reporting strong quarterly earnings and a boosted dividend.
	2025-01-13	+1.08 %
Becton Dickinson (BDX) stock rose by 1.08% following increased investment by Harbor Capital Advisors and other institutional investors, alongside positive analyst upgrades and better-than-expected quarterly earnings results. Becton Dickinson (BDX) stock increased by 1.08% following the company’s strong quarterly earnings report, which showed better-than-expected earnings per share and revenue growth, alongside positive analyst upgrades and a recent dividend increase. Becton, Dickinson and Company (BDX) stock rose by 1.08% following increased institutional investments, particularly by Wealth Enhancement Advisory Services LLC, and positive earnings performance that exceeded consensus estimates for the last quarter.
	2025-01-10	-0.32 %
Becton Dickinson (BDX) stock declined by 0.32% primarily due to increased competition in the medical gas industry, negative investor sentiment linked to its financial performance, and challenges faced in the market.
	2024-12-20	+1.72 %
Becton, Dickinson and Company (BDX) stock rose 1.72% following a series of recent positive analyst reports, including an upgrade from Citigroup and overall favorable ratings indicating a "Moderate Buy" consensus, despite a downgrade from StockNews.com. The stock's increase can be attributed to its recent quarterly earnings report exceeding expectations, with revenue growth and positive future earnings forecasts contributing to investor confidence.
	2024-12-19	-0.12 %
Becton, Dickinson and Company (BDX) stock declined by 0.12% following a downward revision by Zacks Research of its FY2027 earnings per share estimate from $16.75 to $16.68, which indicates a less favorable outlook for the company's future financial performance.
	2024-12-17	-0.84 %
Becton, Dickinson and Company (BDX) stock experienced a decline of 0.84%, despite a consensus "Buy" rating from analysts and a recent earnings report that exceeded expectations; potential factors for the drop could include insider selling and concerns surrounding the stock's overall valuation amidst broader market trends.
	2024-12-09	+1.36 %
Becton Dickinson (BDX) stock rose by 1.36% as Janus Henderson Group PLC increased its stake in the company, along with other institutional investors adding to their holdings, contributing to a positive outlook following strong earnings reports and an increased quarterly dividend.
	2024-12-02	+0.41 %
Becton, Dickinson and Company (BDX) stock rose 0.41% likely due to positive quarterly earnings that exceeded expectations, an increase in target price ratings from several analysts, and the announcement of a higher quarterly dividend to be paid to shareholders. Becton, Dickinson and Company (BDX) stock rose by 0.41% following an increase in Q1 2025 earnings per share estimates by Zacks Research, which boosted confidence among investors and led to upgrades and favorable ratings from several research firms.
	2024-11-22	-0.64 %
Becton, Dickinson and Company (BDX) stock dropped 0.64%, despite recent positive institutional investments and earnings results, potentially due to market volatility or mixed analyst ratings that may have influenced investor confidence.
	2024-11-15	-0.89 %
Becton, Dickinson and Company (BDX) stock decreased by 0.89% due to a combination of market fluctuations and various recent changes in institutional investors’ positions, though it has received positive ratings from some analysts following its latest earnings report.
	2024-11-13	-0.02 %
Becton Dickinson (BDX) stock experienced a slight decline of 0.02% following a downgrade in Q1 2025 earnings per share estimates from research analysts at William Blair, who lowered their forecast from $3.17 to $3.13. Becton, Dickinson and Company (BDX) stock fell by 0.02% due to mixed sentiments reflected in institutional investment activity and analysts' ratings, despite a recent earnings beat and an increased dividend announcement.
	2024-11-12	-1.42 %
Becton, Dickinson and Company (BDX) stock recently experienced a decline of 1.42%, despite the company reporting earnings that beat analysts' expectations, possibly due to broader market trends or investor profit-taking after its previous highs.
	2024-11-08	+1.99 %
Becton, Dickinson and Company (BDX) stock rose by 1.99% following strong quarterly earnings that exceeded analyst expectations and a favorable consensus among institutional investors increasing their stakes in the company.